Log in
A+ A A-

Drug Pushing in the New Europe

A new study reveals how drug reimbursement policy in Poland is leaving gaping loopholes for pharmaceutical firms to exploit, raising questions about other, post-communist, EU member states

 

This may be part of a broader syndrome of the prominence of informal institutions in post-communist policy-making. For the New Europe, this could be a warning." —Lawrence King

An investigation by academic researchers has revealed how backroom deals and discreet pressure by pharmaceutical corporations are determining which drugs are delivered to hospital patients in Poland.

The study, which is described by one of its authors as a “warning for the New Europe”, was led by sociologists at the University of Cambridge, UK. It calls for an overhaul of Poland’s drugs reimbursement system – the process by which government effectively signs off new drugs for use – and suggests that flaws in the system allow some treatments to be employed for therapeutic programmes even though their effectiveness is not guaranteed.

(0 votes)
Tagged under

Safety and Tolerability of the Oral Xa Inhibitor Darexaban for Secondary Prevention After Acute Coronary Syndromes: the RUBY-1 Trial

Hot Line III - Acute Coronary Syndromes

Topics: Acute Coronary Syndromes (ACS)

Paris, France, 30 August: A phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban was associated with a two to four-fold increase in bleeding when added to dual antiplatelet therapy in patients following an acute coronary syndrome.

Professor Gabriel Steg from the Hôpital Bichat in Paris, presenting results from the RUBY-1 trial in a Hot Line session of the ESC Congress today, said the study produced no other safety concerns and that "establishing the role of low-dose darexaban in preventing major cardiac events after ACS now requires a large phase III trial".

(0 votes)

Appropriate Treatment of Chronic Pain and Prevention of Drug Over-dose Deaths Needs to be a Priority for Military Medicine and American Healthcare

A Position Statement from the American Academy of Pain Medicine

 

Glenview, IL- Several recent unintentional deaths of military personnel have drawn national attention on major news websites and Sunday morning television talk shows. While these deaths are tragic and deserve deep societal mourning and introspection, the pain experts from the American Academy of Pain Medicine (AAPM) urge media and government officials to rightly assess the many complexities of these deaths so that viable solutions can be put in place to save lives and help people with chronic pain.

Because the loss of life is such an emotional issue, it is natural to want to assign blame for the cause of these deaths. For instance, the focus of recent reports touched on the problems of over-medication, but experts remind us that there are many difficult paths for those living with chronic pain and related serious consequences from traumas experienced in war zones, including functional loss, brain injury and depression. Suicide risk is a very serious concern that requires ongoing assessment.

(0 votes)
Subscribe to this RSS feed

39°F

New York

Fair

Humidity: 20%

Wind: 7 mph

  • 5 Apr 2016 43°F 29°F
  • 6 Apr 2016 49°F 44°F